The United States is sending doses of an experimental Ebola treatment to the Democratic Republic of Congo for use in clinical trials as the outbreak expands. RFI and Daily Sabah both report that the shipment is intended to support trial-based care, with US and World Health Organization (WHO) officials indicating the effort is part of a widening response. The WHO and US officials say the outbreak has surpassed 1,000 cases and recorded more than 250 deaths, underscoring the scale of the public health emergency. Daily Sabah describes the US as taking a more direct role by providing an experimental antibody drug for trial expansion. RFI similarly notes that the treatment is being released for clinical trial purposes and that the drugs are being shipped to the country. The reports align on the core points: the US supplies experimental Ebola drug doses to DRC, the use is tied to clinical trials, and the decision comes amid a growing outbreak with substantial case and death counts reported by the WHO and US officials.